|
Effects of the Adiponexin formulation on the composition of the intestinal microbiome and weight regulation in individuals with a Body Mass Index greater than or equal to 25 |
|
Effect of the high-precision symbiotic formulation OptiGutPro EDC-HHA02 in treatment of Idiopathic Inflammatory Bowel Disease |
|
CIMAvax®-EGF in patients with moderate-severe chronic obstructive pulmonary disease (COPD) |
|
Prevenox Plus versus original Prevenox: Comparison of effects in healthy volunteers |
|
Nasalferon in respiratory infections in adults. Phase 3 clinical trial. |
|
Intranasal chlorpheniramine (0.4%) for the perennial allergic rhinitis (AR) treatment in adults. Phase IV. |
|
Phase II-III study to evaluate the safety and immunogenicity of the pneumococcal vaccine candidate VCN11 in adult participants aged 50 to 74 years. |
|
Efficacy and safety of SURFACEN® administration by tracheal catheterization in preterm neonates with respiratory distress syndrome. Phase II/III |
|
Evaluation of the safety and the therapeutic effect of the Guanabana infusion in patients with breast cancer |
|
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19. |
|
Safety and effect of Itolizumab in extracorporeal circulation, phase I/II |
|
Phase II-III clinical trial to evaluate the vaccine candidate against pneumococcal diseases VCN11 in infants |
|
Effect and safety of the nutritional supplement Diamel Oral Solution® compared with placebo, in patients with diabetic macular edema without involvement of the macular center, treated or not with laser. Phase II |
|
Nimotuzumab in Esophagus premalignant lesions |
|
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkers |
|
Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. |
|
Effect of the prebiotic OCEAN ACTIVES® Fucoidan in promoting a healthy intestinal microbiome |
|
Effect and Safety of the nebulized surfactant SURFACEN® in the treatment of broncho-obstructive syndrome in children. Exploratory Phase |
|
Effect of the probiotic supplement EDC-HHA01 (OptiBiotics Plus) in the treatment of Type 2 Diabetes Mellitus. |
|
Soft capsules with ozonated sunflower oil versus oral OLEOZON® in patients with Giardiosis |
